Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
S100A12
is a calcium-binding protein of the S100 subfamily of myeloid-related proteins that acts as an alarmin to induce a pro-inflammatory innate immune response. It has been linked to several chronic inflammatory diseases, however its role in the common oral immunopathology
periodontitis
is largely unknown. Previous
in vitro
monoculture experiments indicate that
S100A12
production decreases during monocyte differentiation stages, while the regulation within tissue is poorly defined. This study evaluated
S100A12
expression in monocyte subsets, during monocyte-to-macrophage differentiation and following polarization, both in monoculture and in a tissue context, utilizing a three-dimensional co-culture oral tissue model. Further, we explored the involvement of
S100A12
in
periodontitis
by analyzing its expression in peripheral circulation and gingival tissue, as well as in saliva. We found that
S100A12
expression was higher in classical than in non-classical monocytes.
S100A12
expression and protein secretion declined significantly during monocyte-to-macrophage differentiation, while polarization of monocyte-derived macrophages had no effect on either. Peripheral monocytes from
periodontitis
patients had higher
S100A12
expression than monocytes from controls, a difference particularly observed in the intermediate and non-classical monocyte subsets. Further, monocytes from
periodontitis
patients displayed an increased secretion of
S100A12
compared with monocytes from controls. In oral tissue cultures, monocyte differentiation resulted in increased
S100A12
secretion over time, which further increased after inflammatory stimuli. Likewise,
S100A12
expression was higher in gingival tissue from
periodontitis
patients where monocyte-derived cells exhibited higher expression of
S100A12
in comparison to non-
periodontitis
tissue. In line with our findings, patients with severe
periodontitis
had significantly higher levels of
S100A12
in saliva compared to non-
periodontitis
patients, and the levels correlated to clinical periodontal parameters. Taken together,
S100A12
is predominantly secreted by monocytes rather than by monocyte-derived cells. Moreover,
S100A12
is increased in inflamed tissue cultures, potentially as a result of enhanced production by monocyte-derived cells. This study implicates the involvement of
S100A12
in
periodontitis
pathogenesis, as evidenced by increased
S100A12
expression in inflamed gingival tissue, which may be due to altered circulatory monocytes in
periodontitis
.
...
PMID:S100A12 Expression Is Modulated During Monocyte Differentiation and Reflects Periodontitis Severity. 3208 30